Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corp (symbol: DDD) is a pioneer in the 3D printing industry, offering a broad array of 3D printing and digital manufacturing solutions. The company's product portfolio includes 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. With over 35 years of experience, 3D Systems is at the forefront of innovation in additive manufacturing, impacting a wide range of industries from healthcare and dental to aerospace, automotive, and durable goods.
3D Systems' operations are segmented into Healthcare Solutions and Industrial Solutions, with a significant portion of its revenue generated from the Industrial segment. The company has a strong global presence with offices and facilities across the Americas, EMEA, and APAC regions, although the majority of its revenue comes from the Americas.
The company's recent projects have showcased its advanced capabilities in both industrial and healthcare applications. For instance, 3D Systems has pioneered a first-to-market solution for jetted, monolithic dentures, combining bespoke materials to deliver high-performance dental prosthetics. This innovation has gained interest from leading dental labs and is expected to receive FDA clearance in the second half of 2024.
On the industrial front, 3D Systems continues to expand its portfolio. Recently, the company has seen growth in its metal 3D printing division with Wilting, an industrial machining and metal 3D printing service provider, adding multiple DMP Flex 350 metal 3D printers to its production line. This expansion will enable Wilting to meet increasing customer demand more efficiently.
Financially, 3D Systems has been proactive in managing its liabilities and maintaining a strong balance sheet. The company recently entered into repurchase agreements to buy back $110 million of its 0% Convertible Senior Notes due 2026, thereby reducing its outstanding debt significantly.
3D Systems' commitment to innovation is further exemplified by its developments in patient-specific medical devices. The FDA recently cleared its VSP® PEEK Cranial Implant solution, designed for use in cranioplasty procedures, which utilizes additive manufacturing to produce highly customized, cost-effective cranial implants.
Looking ahead, 3D Systems aims to harness its leadership in digital dentistry, with plans to expand its product offerings to include night guards and direct-printed clear aligners. The company has also secured a multi-year purchase agreement, valued at nearly a quarter-billion dollars, to support the indirect manufacturing process for clear aligners, a testament to its robust 3D printing technology and market leadership.
3D Systems' unique combination of hardware, software, materials, and services, powered by expert application engineers, ensures they continue to transform industries and empower their customers to innovate. More information on 3D Systems is available at www.3dsystems.com.
Systemic Bio, a 3D Systems (NYSE: DDD) company, has been selected as a Top 10 Finalist for the SLAS 2025 Innovation Award. The company's proprietary h-VIOS™ platform, which accelerates drug discovery using bioprinted tissues, earned this recognition at the SLAS International Conference and Exhibition.
Operating from a Houston-based ISO 7 clean room facility under a Quality Management System, Systemic Bio can produce thousands of tissue models that mimic human organ systems with high precision. The platform represents a significant advancement in preclinical testing, supporting collaborations with leading pharmaceutical companies.
CEO Taci Pereira emphasized the recognition's significance in highlighting their platform's transformative potential in pharmaceutical innovation. Systemic Bio will present "h-VIOS: A human-relevant drug discovery and development platform using bioprinted human tissues" at the SLAS Conference in San Diego on January 27, 2025. The winner announcement is scheduled for January 29, 2025.
3D Systems (NYSE:DDD) has announced its participation in the 27th Annual Needham Growth Conference scheduled for January 14, 2025. The company's President and CEO, Dr. Jeffrey Graves, will engage in a fireside chat at 11:45 a.m. Eastern Standard Time and conduct individual meetings with the company's leadership team throughout the day.
A live webcast of the conference presentation will be accessible through 3D Systems' Investor Relations page. The webcast link will become active shortly before the event begins and will be available for on-demand viewing approximately 24 hours after the event concludes, with -time access following the conference.
3D Systems (NYSE:DDD) has announced the sale of its Geomagic® software portfolio to Hexagon's Manufacturing Intelligence Division for $123 million. The transaction is expected to close in the first half of 2025. Following this strategic divestiture, 3D Systems will focus on its core software platforms: 3D Sprint®, 3DXpert®, and Oqton Industrial Manufacturing OS.
The company aims to sharpen its focus on software solutions that accelerate the adoption of 3D printing technologies in large-scale production environments. This strategic shift will emphasize leveraging AI and machine learning capabilities to enhance workflows, improve productivity, reduce costs, and enhance component quality in production settings.
3D Systems (NYSE:DDD) reported Q3 2024 financial results with revenue of $112.9 million, down 9% year-over-year. The decline was primarily due to weak printer sales, partially offset by 10% growth in consumables. Healthcare Solutions revenue grew 5% to $55.1 million. The company reported a net loss of $178.6 million, including $143.7 million from goodwill impairment. Q3 gross profit margin was 36.9%, down from 44.7% last year. The company updated its FY2024 guidance, expecting revenues between $440-450 million. Cash position stood at $190.0 million as of September 30, 2024.
3D Systems (NYSE:DDD) announced it will release its Q3 2024 financial results after market close on Tuesday, November 26, 2024, followed by a conference call on Wednesday, November 27. The company received a NYSE Notice on November 19 for non-compliance with listing requirements due to delayed filing of its Q3 Form 10-Q. While this notice doesn't immediately affect DDD's NYSE listing, the company has six months to regain compliance. 3D Systems expects to resolve this by filing the Form 10-Q on November 26, 2024.
3D Systems (NYSE:DDD) announced that Sauber Motorsports will enhance its manufacturing workflow with 10 new 3D printers - eight SLA 750 Dual and two PSLA 270 units. The implementation aims to accelerate wind tunnel testing and increase production capacity. The SLA 750 Dual, recognized as the fastest Stereolithography solution available, offers superior print size, speed, and accuracy. Sauber becomes the first Formula 1 team to adopt the new PSLA technology, which combines accuracy with speed. The partnership builds on a nearly two-decade relationship between the companies, supporting the growing automotive 3D printing market, which is projected to reach $7.9 billion by 2027.
3D Systems (NYSE:DDD) announced preliminary Q3 2024 revenue of approximately $112.9 million, representing a $10.9 million decrease from Q3 2023's $123.8 million. The decline was primarily due to macroeconomic factors affecting hardware systems sales. However, consumable materials revenue grew 10% year-over-year and 9% sequentially. The company's Personalized Healthcare business showed strong performance with nearly 20% growth. The company secured FDA clearances for multi-material jetted dentures and TOTAL ANKLE Patient-Matched Guides. The Q3 2024 Form 10-Q filing is delayed due to required interim valuation of goodwill and long-lived assets.
3D Systems (NYSE:DDD) announces multiple new products at Formnext 2024, including the PSLA 270 platform with Wash 400/Wash 400F and Cure 400 post-processing solutions. The company introduces Figure 4 Rigid Composite White and Accura AMX Rigid Composite White materials in Europe, designed for high-stiffness parts production. The launch includes new materials for SLS and MultiJet Printing platforms, plus a new powder management system for the DMP Flex 200. These innovations aim to accelerate production speed, improve part quality, and enhance manufacturing efficiency.
3D Systems (NYSE:DDD) has received FDA 510(k) clearance for its innovative multi-material, monolithic jetted denture solution. This first-to-market offering combines NextDent® Jet Denture Teeth and NextDent® Jet Denture Base materials with 3D Systems' jetting technology, software, and services. The solution enables the production of durable, long-wear, and aesthetically pleasing dentures in a single print session.
Glidewell, a major dental device producer, is implementing this solution into its production workflow. The FDA clearance represents a significant milestone in 3D Systems' strategic initiative to expand its digital dentistry solution portfolio. This new denture product family is expected to tap into a market estimated to exceed $2 billion by 2028, significantly expanding the company's addressable dental market.
3D Systems (NYSE:DDD) has received FDA 510(k) clearance for its TOTAL ANKLE Patient-Matched Guides, designed to work with Smith+Nephew's total ankle replacement solutions. This expansion of 3D Systems' orthopedic surgical planning portfolio leverages the company's VSP surgical planning workflows and advanced 3D printing technologies. The patient-specific guides aim to improve surgical efficiency and accuracy while reducing procedural steps and operating room time.
Key highlights include:
- Over 175,000 patient-matched cases supported
- Collaboration with Smith+Nephew for tailored total ankle replacement surgery
- Potential for reduced intraoperative x-ray radiation
- Expansion into large joint and trauma applications
- Growing orthopedic devices market, anticipated to reach $5.3 billion by 2032
FAQ
What is the current stock price of 3D Systems (DDD)?
What is the market cap of 3D Systems (DDD)?
What does 3D Systems Corp do?
What are the main segments of 3D Systems' business?
What recent innovations has 3D Systems introduced?
How is 3D Systems expanding its digital dentistry portfolio?
What is the significance of 3D Systems' recent debt repurchase?
How does 3D Systems impact the healthcare industry?
What are some of the industries served by 3D Systems?
Where does 3D Systems generate most of its revenue?
What is 3D Systems' approach to supporting customer demand?
How long has 3D Systems been in the 3D printing industry?
